The GPCRact AI model goes beyond AlphaFold3 by predicting whether drugs functionally activate G-protein-coupled receptors ...
A new light-driven chemical reaction enables scientists to modify drug molecules at late stages of development. The method ...
Explore the capabilities of a new AI tool that revolutionizes drug discovery by speeding up molecule formation and reducing ...
Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.
Explore SLAS Boston 2026 insights on connecting laboratory automation and data infrastructure in drug discovery workflows.
A surprising lab discovery reveals a light-powered way to tweak complex drugs faster, cleaner, and later in development.
An experimental drug reduced seizures by up to 91% in children with Dravet syndrome. | Drug Discovery And Development ...
Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...
Artificial intelligence and machine learning are being embedded in every aspect of the drug discovery and development process. In the preclinical stages, for example, companies are using advanced AI ...
A new study reveals that the world’s most widely used diabetes drug works through a previously unknown brain pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results